Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eupatilin for prevention of NSAID-induced enteropathy in patients also taking proton pump inhibitors
KCT0006208Phase 4Not yet recruiting
- Sponsor
- Dong-A ST
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of eupatilin in non-steroidal anti-inflammatory drug-induced enteropathy (NSAID-E) (2 arms), sponsored by Dong-A ST. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
eupatilin
03
Conditions
non-steroidal anti-inflammatory drug-induced enteropathy (NSAID-E)
Beyond the preview
Go deeper on KCT0006208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006208.